- Report
- February 2024
- 175 Pages
Global
From €4906EUR$5,000USD£4,080GBP
- Report
- November 2024
- 164 Pages
Global
From €5347EUR$5,450USD£4,447GBP
- Report
- July 2024
- 142 Pages
Global
From €3826EUR$3,899USD£3,182GBP
- Report
- January 2024
- 200 Pages
Global
From €4072EUR$4,150USD£3,387GBP
- Report
- July 2024
- 121 Pages
North America
From €3629EUR$3,699USD£3,019GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1374EUR$1,400USD£1,142GBP
€1962EUR$2,000USD£1,632GBP
- Report
- July 2024
- 162 Pages
Africa
From €2453EUR$2,500USD£2,040GBP
- Report
- July 2024
- 288 Pages
Global
From €5413EUR$5,710USD£4,350GBP
- Report
- October 2024
- 195 Pages
Global
From €3478EUR$3,545USD£2,893GBP
€3865EUR$3,939USD£3,214GBP
- Report
- October 2024
- 192 Pages
Global
From €3478EUR$3,545USD£2,893GBP
€3865EUR$3,939USD£3,214GBP
- Report
- October 2024
- 190 Pages
Global
From €3478EUR$3,545USD£2,893GBP
€3865EUR$3,939USD£3,214GBP
- Report
- October 2024
- 192 Pages
Global
From €3478EUR$3,545USD£2,893GBP
€3865EUR$3,939USD£3,214GBP
- Report
- October 2024
- 192 Pages
Global
From €3478EUR$3,545USD£2,893GBP
€3865EUR$3,939USD£3,214GBP
- Report
- October 2024
- 198 Pages
Global
From €3478EUR$3,545USD£2,893GBP
€3865EUR$3,939USD£3,214GBP
- Report
- March 2024
- 118 Pages
Global
From €4415EUR$4,500USD£3,672GBP
- Report
- May 2024
- 134 Pages
Global
From €6377EUR$6,499USD£5,303GBP
- Report
- June 2024
- 200 Pages
Global
From €5460EUR$5,565USD£4,541GBP
€7800EUR$7,950USD£6,488GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1374EUR$1,400USD£1,142GBP
€1962EUR$2,000USD£1,632GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1374EUR$1,400USD£1,142GBP
€1962EUR$2,000USD£1,632GBP
- Drug Pipelines
- April 2024
- 50 Pages
Global
From €1030EUR$1,050USD£857GBP
€1472EUR$1,500USD£1,224GBP
The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more